Celgene Corporation (NASDAQ: CELG)

Celgene Corporation (NASDAQ: CELG), a multinational biopharmaceutical company, is dedicated improving the lives of patients worldwide by delivering novel and life-changing drugs. Their aim is to build a major global biopharmaceutical corporation while discovering, developing, and commercializing products for the treatment of cancer and other severe, immune, inflammatory conditions. For further information, visit the Company’s web site at www.celgene.com.